Immediate Impact
38 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Works of Pablo Mozas being referenced
Past, present and future of prognostic scores in follicular lymphoma
2021
Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Pablo Mozas | 208 | 134 | 121 | 35 | 266 | |
| Vít Campr | 197 | 139 | 112 | 45 | 312 | |
| Juraj Ďuraš | 139 | 171 | 27 | 35 | 231 | |
| Massimo Federico | 134 | 109 | 38 | 53 | 236 | |
| Ewa Paszkiewicz‐Kozik | 138 | 156 | 38 | 57 | 302 | |
| Antonella Anastasia | 211 | 161 | 76 | 21 | 278 | |
| Subhayan Chattopadhyay | 104 | 119 | 66 | 36 | 309 | |
| Maria Cristina Pirosa | 143 | 111 | 48 | 26 | 286 | |
| Claudia Mannu | 147 | 111 | 66 | 19 | 206 | |
| Sylvia Snauwaert | 117 | 174 | 50 | 33 | 304 | |
| Stefan Alig | 119 | 109 | 35 | 28 | 229 |
All Works
Login with ORCID to disown or claim papers
Loading papers...